Downregulation of β-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency

Gynecological Endocrinology

Volumn 23, Issue 9, 2007, Pages 535-540

  Foo, Clara ^a   Frey, Soenke ^a,b   Yang, Hong Hyun ^a,c   Zellweger, Rene ^b   Filgueira, Luis ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Chonbuk National University   (South Korea)

Author keywords

catenin; Adipocytes; Estrogens; Osteoblasts; Wnt

Indexed keywords

ANTIESTROGEN; BETA CATENIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; TRANSCRIPTION FACTOR;

ADIPOCYTE; ARTICLE; BONE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ESTROGEN DEFICIENCY; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MICROSCOPY; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC ANIMAL; WESTERN BLOTTING;

ADIPOCYTES; BETA CATENIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; OSTEOBLASTS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 35448941398     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701556483     Document Type: Article

References (31)

1. Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279-302.
2. Gimble JM, Zvonic S, Floyd ZL, Kassem M, Nuttall ME. Playing with bone and fat. J Cell Biochem 2006;98:251-266.
3. Ahdjoudj S, Fromigue O, Marie PJ. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol Histopathol 2004;19:151-157.
4. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004;4:290-294.
5. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β. Endocrinology 2002;143:2349-2356.
6. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 2005;102:3324-3329.
7. Kennell JA, MacDougald OA. Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms. J Biol Chem 2005;280:24004-24010.
8. Liu J, Farmer SR. Regulating the balance between peroxisome proliferator-activated receptor γ and β-catenin signaling during adipogenesis. A glycogen synthase kinase 3β phosphorylation-defective mutant of β-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 2004;279:45020-45027.
9. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, et al. Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem 2004;279:40255-40258.
10. Filgueira L, Meagher J, Al-Mushaiqri M, Skirving AP, Zellweger R. Fulvestrant, an estrogen receptor antagonist, blocks proliferation and differentiation of cultured primary human osteoblasts. Bone 2005;36:S463-S464.
11. Harris SA, Enger RJ, Riggs BL, Spelsberg TC. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995;10:178-186.
12. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-137.
13. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev 2000;14:1293-1307.
14. Robinson JA, Harris SA, Riggs BL, Spelsberg TC. Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 1997;138:2919-2927.
15. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000;289:950-953.
16. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signalling in osteoblasts and bone diseases. Gene 2004;341:19-39.
17. Wakeling AE. Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr Relat Cancer 2000;7:17-28.
18. Gronthos S, Zannettino ACW, Graves SE, Ohta S, Hay SJ, Simmons PJ. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999;14:47-56.
19. Yen ML, Chien CC, Chiu IM, Huang HI, Chen YC, Hu HI, Yen BL. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 2007;25:125-131.
20. Ahdjoudj S, Lasmoles F, Oyajobi BO, Lomri A, Delannoy Ph, Marie PJ. Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1+ cells. J Cell Biochem 2001;81:23-38.
21. Reid G, Denger S, Kos M, Gannon F. Human estrogen receptor-α: regulation by synthesis, modification and degradation. Cell Mol Life Sci 2002;59:821-831.
22. Pink JJ, Fritsch M, Bilimoria MM, Assikis VJ, Jordan VC. Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line. Br J Cancer 1997;75:17-27.
23. Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F. ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 2001;15:2064-2077.
24. Penot G, Le Peron C, Merot Y, Grimaud-Fanouillere E, Ferriere F, Boujrad N, Kah O, Saligaut C, Ducouret B, Metivier R, et al. The human estrogen receptor-α isoform hERα46 antagonizes the proliferative influence of hERα66 in MCF7 breast cancer cells. Endocrinology 2005;146:5474-5484.
25. Osborne CK, Wakeling A, Nicholson RI. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 2004;90:S2-S6.
26. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R. β-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 2005;94:4003-4018.
27. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 2007;27:1516-1530.
28. Hartman C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol 2006;16:151-158.
29. Bodine PVN, Komm BS. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 2006;7:33-39.
30. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005;280:19887.
31. Tu X, Joeng KS, Nakayama K, Nakayama K, Rajagopal J, Carroll TJ, McMahon AP, Long F. Noncanonical Wnt signaling through G protein-linked PKCδ activation promotes bone formation. Dev Cell 2007;12:113-127.